Limbal stem cell deficiency secondary to systemic paclitaxel (Taxol) for breast cancer: a case report

BACKGROUND: Paclitaxel (PTX) is an antineoplastic drug widely used in treatments for ovarian, breast, and small-cell lung cancer. Although ocular effects associated with PTX have been previously described, very few studies have specifically reported systemic PTX as a contributing factor for limbal s...

Descripción completa

Detalles Bibliográficos
Autores principales: Sekhon, Amardeep, Wang, Jeff Y. F., Tan, Johnson C. H., Holland, Simon P., Yeung, Sonia N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542760/
https://www.ncbi.nlm.nih.gov/pubmed/33028255
http://dx.doi.org/10.1186/s12886-020-01672-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7542760/
https://www.ncbi.nlm.nih.gov/pubmed/33028255
http://dx.doi.org/10.1186/s12886-020-01672-x

Ejemplares similares